November 18, 2024 Pharma | BioTech GTN Summit 2024 As a bronze sponsor of the Informa Connect Pharma Biotech GTN Summit 2024 conference, hosted in Philadelphia November 18-20, 2024, IntegriChain’s consulting team will participate in various sessions. Join us on Monday, November 18 as we kick off the conference with our RAC Industry Hot Topic Roundtables from 4:30 – 6:00. Jen Sharpe and others will discuss: Government Impacts on GTN: IRA Part D/B Rebates, MFP & AMP Cap Removal Coverage Gap Redesign: Successful Predictive Modeling GTN Monthly Close: Successful Practices & Methodologies All Things 340B: Analyzing Revenue Leakage & Tackling Contract Pharmacies Wrangling GTN Data Sources: 3PL, Copay Vendor, ERP, Adjudication Application Patient & Access Program Impact on GTN: Copay, Bridge, Voucher, Digital Pharmacies Payer Pressures on GTN: Understanding Shifts in Rebates, Admin Fees & Price Protection Protection Demand & Inventory Mgt: Reconciling Pipeline against Sales and Demand Product Launch: Successful GTN Roadmap to Launch Returns: Successful Vendors, Analogs and Methodologies Our subject matter experts take the stage Tuesday and Wednesday. We look forward to seeing you there. Jen SharpeVice President, Gross-To-Net Consulting Session: Updated Evolution and Scalability for Clinical to Commercial Preparedness Date/Time: Tuesday, November 19 – 3:45 – 5:00 PM Session Description: Jen Sharpe, Vice President, Gross-To-Net Consulting will be joined by Chris Prentiss, CFO – Mannkind, as they discuss Top 10 launch considerations Gradual product launch additions and considerations for manageability Managing scalability within your company and department Post-launch expectations and looking to years ahead Operational best practices Pain points and challenges Jeff BaabPartner, Advisory Services Session: Evaluating the Impact of Medicare Negotiation and & Healthcare Policy Updates Date/Time: Wednesday, November 20 – 9:30 – 10:15 AM Description: From Medicare Negotiation to a new CMS Final Rule to the popping of the proverbial gross-to-net bubble, the volume and magnitude of changes impacting pricing, contracting and market access decisions continues to unfold at an unprecedented pace. Jeff Baab, Partner, Advisory Services will discuss how the multitude of market events, landmark policy decisions, and stakeholder reactions are influencing how pharma stakeholders will continue to evolve and react and how it may impact GTN. To assist in registration, use code 24INTEGRI10 for 10% off the summit registration fee. REGISTER NOW
